Jaguar Health, Inc. (JAGX) Stock Overview
Explore Jaguar Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Jaguar Health, Inc. (JAGX)
Key Financials
Key Financials
Market Cap
2.6M
P/E Ratio
-0.00
EPS (TTM)
$-43.74
ROE
7.63%
JAGX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Jaguar Health, Inc. (NASDAQ: JAGX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Jaguar Health, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of JAGX on the NASDAQ shows an RSI of 51.16, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Jaguar Health, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.00 and a market capitalization of 2.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of JAGX on the NASDAQ.